What is the typical multimodal treatment approach for chest wall sarcomas?

What is the typical multimodal treatment approach for chest wall sarcomas?

• A. Neoadjuvant chemo +/- radiation, resection, and adjuvant chemo +/- radiation
• B. Radiation alone
• C. Observation
• D. Antibiotics

Answer: (A)

Chest wall sarcomas demand both systemic control and strong local control to maximize outcomes. The best approach uses chemotherapy before surgery, with or without radiation, to shrink the tumor and tackle microscopic disease. This neoadjuvant step can make it easier to achieve a complete, wide-margin resection, which is essential for durable local control given the chest wall’s anatomy. After removing the tumor, additional chemotherapy and/or radiotherapy is tailored to the histology, margins, and risk of recurrence to further reduce relapse. This multimodal sequence—neoadjuvant therapy, followed by resection, then adjuvant therapy—is superior to relying on radiation alone, observation, or antibiotics, because it addresses both systemic and local disease comprehensively.

Chest wall sarcomas demand both systemic control and strong local control to maximize outcomes. The best approach uses chemotherapy before surgery, with or without radiation, to shrink the tumor and tackle microscopic disease. This neoadjuvant step can make it easier to achieve a complete, wide-margin resection, which is essential for durable local control given the chest wall’s anatomy. After removing the tumor, additional chemotherapy and/or radiotherapy is tailored to the histology, margins, and risk of recurrence to further reduce relapse. This multimodal sequence—neoadjuvant therapy, followed by resection, then adjuvant therapy—is superior to relying on radiation alone, observation, or antibiotics, because it addresses both systemic and local disease comprehensively.